Credit Suisse Reiterates Outperform on Privia Health Gr, Maintains $41 Price Target
Portfolio Pulse from richadhand@benzinga.com
Credit Suisse analyst Jonathan Yon reiterated an Outperform rating on Privia Health Gr (NASDAQ:PRVA) and maintained a $41 price target.

June 22, 2023 | 11:47 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Credit Suisse analyst Jonathan Yon reiterated an Outperform rating on Privia Health Gr (NASDAQ:PRVA) and maintained a $41 price target.
The reiteration of an Outperform rating by Credit Suisse analyst Jonathan Yon indicates a positive outlook for Privia Health Gr's stock price in the short term. The maintained $41 price target suggests that the analyst believes the stock has potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100